US concerns on key drugs wreck Aurobindo’s plan to buy Sandoz biz

The FTC was not convinced on several issues pertaining to continued availability of these critical drugs and didn’t accept the alternatives suggested by the two companies to allay the concerns of the regulator, said people in the know.

from Markets-Economic Times https://ift.tt/346wEGL